Copyright Reports & Markets. All rights reserved.

COVID-19 Impact on Global Pertuzumab, Market Insights and Forecast to 2026

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Pertuzumab Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Pertuzumab Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Pertuzumab Market Size Growth Rate by Type
    • 1.4.2 Human Source
    • 1.4.3 Animal Source
  • 1.5 Market by Application
    • 1.5.1 Global Pertuzumab Market Size Growth Rate by Application
    • 1.5.2 Hospital
    • 1.5.3 Medical Center
  • 1.6 Coronavirus Disease 2019 (Covid-19): Pertuzumab Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Pertuzumab Industry
      • 1.6.1.1 Pertuzumab Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Pertuzumab Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Pertuzumab Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Executive Summary

  • 2.1 Global Pertuzumab Market Size Estimates and Forecasts
    • 2.1.1 Global Pertuzumab Revenue 2015-2026
    • 2.1.2 Global Pertuzumab Sales 2015-2026
  • 2.2 Pertuzumab Market Size by Region: 2020 Versus 2026
    • 2.2.1 Global Pertuzumab Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Pertuzumab Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Pertuzumab Competitor Landscape by Players

  • 3.1 Pertuzumab Sales by Manufacturers
    • 3.1.1 Pertuzumab Sales by Manufacturers (2015-2020)
    • 3.1.2 Pertuzumab Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Pertuzumab Revenue by Manufacturers
    • 3.2.1 Pertuzumab Revenue by Manufacturers (2015-2020)
    • 3.2.2 Pertuzumab Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Pertuzumab Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Pertuzumab Revenue in 2019
    • 3.2.5 Global Pertuzumab Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Pertuzumab Price by Manufacturers
  • 3.4 Pertuzumab Manufacturing Base Distribution, Product Types
    • 3.4.1 Pertuzumab Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Pertuzumab Product Type
    • 3.4.3 Date of International Manufacturers Enter into Pertuzumab Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Pertuzumab Market Size by Type (2015-2020)
    • 4.1.1 Global Pertuzumab Sales by Type (2015-2020)
    • 4.1.2 Global Pertuzumab Revenue by Type (2015-2020)
    • 4.1.3 Pertuzumab Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Pertuzumab Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Pertuzumab Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Pertuzumab Revenue Forecast by Type (2021-2026)
    • 4.2.3 Pertuzumab Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Pertuzumab Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Breakdown Data by Application (2015-2026)

  • 5.1 Global Pertuzumab Market Size by Application (2015-2020)
    • 5.1.1 Global Pertuzumab Sales by Application (2015-2020)
    • 5.1.2 Global Pertuzumab Revenue by Application (2015-2020)
    • 5.1.3 Pertuzumab Price by Application (2015-2020)
  • 5.2 Pertuzumab Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Pertuzumab Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Pertuzumab Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Pertuzumab Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Pertuzumab by Country
    • 6.1.1 North America Pertuzumab Sales by Country
    • 6.1.2 North America Pertuzumab Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Pertuzumab Market Facts & Figures by Type
  • 6.3 North America Pertuzumab Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Pertuzumab by Country
    • 7.1.1 Europe Pertuzumab Sales by Country
    • 7.1.2 Europe Pertuzumab Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Pertuzumab Market Facts & Figures by Type
  • 7.3 Europe Pertuzumab Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Pertuzumab by Region
    • 8.1.1 Asia Pacific Pertuzumab Sales by Region
    • 8.1.2 Asia Pacific Pertuzumab Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Pertuzumab Market Facts & Figures by Type
  • 8.3 Asia Pacific Pertuzumab Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Pertuzumab by Country
    • 9.1.1 Latin America Pertuzumab Sales by Country
    • 9.1.2 Latin America Pertuzumab Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Pertuzumab Market Facts & Figures by Type
  • 9.3 Central & South America Pertuzumab Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Pertuzumab by Country
    • 10.1.1 Middle East and Africa Pertuzumab Sales by Country
    • 10.1.2 Middle East and Africa Pertuzumab Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Pertuzumab Market Facts & Figures by Type
  • 10.3 Middle East and Africa Pertuzumab Market Facts & Figures by Application

11 Company Profiles

  • 11.1 Novartis AG
    • 11.1.1 Novartis AG Corporation Information
    • 11.1.2 Novartis AG Description, Business Overview and Total Revenue
    • 11.1.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Novartis AG Pertuzumab Products Offered
    • 11.1.5 Novartis AG Recent Development
  • 11.2 Pfizer
    • 11.2.1 Pfizer Corporation Information
    • 11.2.2 Pfizer Description, Business Overview and Total Revenue
    • 11.2.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Pfizer Pertuzumab Products Offered
    • 11.2.5 Pfizer Recent Development
  • 11.3 Abnova Corporation
    • 11.3.1 Abnova Corporation Corporation Information
    • 11.3.2 Abnova Corporation Description, Business Overview and Total Revenue
    • 11.3.3 Abnova Corporation Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Abnova Corporation Pertuzumab Products Offered
    • 11.3.5 Abnova Corporation Recent Development
  • 11.4 InvivoGen
    • 11.4.1 InvivoGen Corporation Information
    • 11.4.2 InvivoGen Description, Business Overview and Total Revenue
    • 11.4.3 InvivoGen Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 InvivoGen Pertuzumab Products Offered
    • 11.4.5 InvivoGen Recent Development
  • 11.5 Celltrion
    • 11.5.1 Celltrion Corporation Information
    • 11.5.2 Celltrion Description, Business Overview and Total Revenue
    • 11.5.3 Celltrion Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 Celltrion Pertuzumab Products Offered
    • 11.5.5 Celltrion Recent Development
  • 11.6 Biocon Limited
    • 11.6.1 Biocon Limited Corporation Information
    • 11.6.2 Biocon Limited Description, Business Overview and Total Revenue
    • 11.6.3 Biocon Limited Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 Biocon Limited Pertuzumab Products Offered
    • 11.6.5 Biocon Limited Recent Development
  • 11.7 Bio-Techne
    • 11.7.1 Bio-Techne Corporation Information
    • 11.7.2 Bio-Techne Description, Business Overview and Total Revenue
    • 11.7.3 Bio-Techne Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 Bio-Techne Pertuzumab Products Offered
    • 11.7.5 Bio-Techne Recent Development
  • 11.1 Novartis AG
    • 11.1.1 Novartis AG Corporation Information
    • 11.1.2 Novartis AG Description, Business Overview and Total Revenue
    • 11.1.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Novartis AG Pertuzumab Products Offered
    • 11.1.5 Novartis AG Recent Development

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Pertuzumab Market Estimates and Projections by Region
    • 12.1.1 Global Pertuzumab Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Pertuzumab Revenue Forecast by Regions 2021-2026
  • 12.2 North America Pertuzumab Market Size Forecast (2021-2026)
    • 12.2.1 North America: Pertuzumab Sales Forecast (2021-2026)
    • 12.2.2 North America: Pertuzumab Revenue Forecast (2021-2026)
    • 12.2.3 North America: Pertuzumab Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Pertuzumab Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Pertuzumab Sales Forecast (2021-2026)
    • 12.3.2 Europe: Pertuzumab Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Pertuzumab Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Pertuzumab Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Pertuzumab Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Pertuzumab Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Pertuzumab Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Pertuzumab Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Pertuzumab Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Pertuzumab Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Pertuzumab Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Pertuzumab Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Pertuzumab Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Pertuzumab Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Pertuzumab Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter’s Five Forces Analysis
  • 13.5 Primary Interviews with Key Pertuzumab Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Pertuzumab Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source

    Pertuzumab market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Pertuzumab market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

    Segment by Type, the Pertuzumab market is segmented into
    Human Source
    Animal Source

    Segment by Application, the Pertuzumab market is segmented into
    Hospital
    Medical Center

    Regional and Country-level Analysis
    The Pertuzumab market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Pertuzumab market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
    Competitive Landscape and Pertuzumab Market Share Analysis
    Pertuzumab market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Pertuzumab business, the date to enter into the Pertuzumab market, Pertuzumab product introduction, recent developments, etc.
    The major vendors covered:
    Novartis AG
    Pfizer
    Abnova Corporation
    InvivoGen
    Celltrion
    Biocon Limited
    Bio-Techne
    ...

    Buy now